← Back to headlines
FDA Chief Warns US Losing Ground to China in Early Drug Development
The FDA chief warns that the U.S. is falling behind China in early drug development and calls for faster trial approvals to address bottlenecks in hospital contracting, ethical reviews, and Investigational New Drug applications.
18 Feb, 20:35 — 18 Feb, 22:00
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center1
Center (1)
AP
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
APVery High49d ago
FDA will drop two-study requirement for new drug approvals, aiming to speed access - Associated Press News
FDA will drop two-study requirement for new drug approvals, aiming to speed access Associated Press News
Read full article →cnbcMostly Factual49d ago
FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug applications process
Read full article →Coverage Timeline
First report: cnbc · 18 Feb, 20:35|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
